180 related articles for article (PubMed ID: 28542054)
1. Quantitative Neuromuscular Blockade Monitoring: Two Pictures of Unexpected Rocuronium Effect: A Case Report.
Leonard PA; Todd MM
A A Case Rep; 2017 Oct; 9(7):190-192. PubMed ID: 28542054
[TBL] [Abstract][Full Text] [Related]
2. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
3. [Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
Grandjean B; Guerci P; F Vial ; Raft J; Fuchs-Buder T; Bouaziz H
Ann Fr Anesth Reanim; 2013 May; 32(5):378-9. PubMed ID: 23664923
[No Abstract] [Full Text] [Related]
4. Prolonged neuromuscular blockade associated with rocuronium.
Lewis KS; Santucci VN; Normoyle DL; Rothenberg DM
Am J Health Syst Pharm; 1999 Jun; 56(11):1114-8. PubMed ID: 10385459
[No Abstract] [Full Text] [Related]
5. Significantly prolonged neuromuscular blockade after a single dose of rocuronium: The importance of monitoring.
Soares M; Esteves S
Eur J Anaesthesiol; 2016 Sep; 33(9):693-4. PubMed ID: 27136491
[No Abstract] [Full Text] [Related]
6. [Prolonged residual paralysis after a single intubating dose of rocuronium: an unexpected cause].
Guerci P; Vial F; Raft J; Meistelman C; Bouaziz H
Ann Fr Anesth Reanim; 2012; 31(7-8):632-4. PubMed ID: 22763308
[TBL] [Abstract][Full Text] [Related]
7. Extremely prolonged neuromuscular blockade after rocuronium: a case report.
Morales Martín AC; Vaquero Roncero LM; Muriel Villoria C
Acta Anaesthesiol Scand; 2009 Aug; 53(7):957-9. PubMed ID: 19397500
[TBL] [Abstract][Full Text] [Related]
8. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
[TBL] [Abstract][Full Text] [Related]
9. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
[TBL] [Abstract][Full Text] [Related]
10. Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risks.
Hunter JM; Blobner M
Br J Anaesth; 2024 Mar; 132(3):461-465. PubMed ID: 38135525
[TBL] [Abstract][Full Text] [Related]
11. Sugammadex in anesthesia practice.
Duvaldestin P; Plaud B
Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
[TBL] [Abstract][Full Text] [Related]
12. Effects of magnesium sulphate on the pharmacodynamics of rocuronium in patients aged 60 years and older: A randomised trial.
Rotava P; Cavalcanti IL; Barrucand L; Vane LA; Verçosa N
Eur J Anaesthesiol; 2013 Oct; 30(10):599-604. PubMed ID: 23635996
[TBL] [Abstract][Full Text] [Related]
13. [Muscle relaxants in the ICU].
Schneider G
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
[TBL] [Abstract][Full Text] [Related]
15. The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.
Naguib M; Brewer L; LaPierre C; Kopman AF; Johnson KB
Anesth Analg; 2016 Jul; 123(1):82-92. PubMed ID: 27140684
[TBL] [Abstract][Full Text] [Related]
16. Unexpected failure of rocuronium-mediated neuromuscular blockade.
Deckert D; Lederer W; Khuenl-Brady KS
Anaesthesia; 2011 Jan; 66(1):58-9. PubMed ID: 21198505
[No Abstract] [Full Text] [Related]
17. Management of subcutaneous infiltration of rocuronium: A case report.
Timmermann TN; Mongan PD; Hoefnagel AL; Braunecker S
J Clin Anesth; 2021 Aug; 71():110203. PubMed ID: 33609852
[No Abstract] [Full Text] [Related]
18. Sugammadex reversal of rocuronium-induced neuromuscular blockade in two types of neuromuscular disorders: Myotonic dystrophy and spinal muscular atrophy.
Stewart PA; Phillips S; De Boer HD
Rev Esp Anestesiol Reanim; 2013 Apr; 60(4):226-9. PubMed ID: 22947194
[TBL] [Abstract][Full Text] [Related]
19. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report.
Kawano T; Tamura T; Hamaguchi M; Yatabe T; Yamashita K; Yokoyama M
J Clin Anesth; 2012 Feb; 24(1):62-4. PubMed ID: 22154092
[TBL] [Abstract][Full Text] [Related]
20. Prolonged residual paralysis after a single intubating dose of rocuronium.
Claudius C; Karacan H; Viby-Mogensen J
Br J Anaesth; 2007 Oct; 99(4):514-7. PubMed ID: 17675361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
